Claroid Pharmaceuticals Limited IPO — Dates, Price Band, Lot Size, Financials & Prospectus Analysis | Anvest

DRHP Filed — Dates AwaitedMAINBOARDOfficial SEBI Filing

Claroid Pharmaceuticals Limited

Price Band

—

Total Issue Size

—

Bidding Window

—

Market Lot

—

Subscription

—

Issue Timeline & Lifecycle

DRHP Filed

30 Sept 2026

Issue Opens

Not announced

Issue Closes

Not announced

Allotment

Not announced

Exchange Debut

Not announced

DRHP Filed

30 Sept 2026

Issue Opens

Not announced

Issue Closes

Not announced

Allotment

Not announced

Exchange Debut

Not announced

AI Company Profile

AI Snapshot

Claroid Pharmaceuticals Limited IPO

HQ:S.No -217/P, Opp Gurukul English School, Kamod-Pirana Road, Pirana, Ahmedabad, Daskroi – 382425, Gujarat, India.

What Looks Strong

The offer document states no strength that could be verified.

What to Watch

The offer document states no risk factor that could be verified.

Fundamentals & Key Metrics

Period:FY26

Profitability & Returns

6 items

EBITDA Marginℹ

24.12%

Profit Marginℹ

13.06%

RoNWℹ

68.73%

ROCEℹ

52.66%

Basic EPSℹ

₹5.41

Book Valueℹ

₹10.57

Financial Health & Solvency

2 items

Net Worthℹ

₹44.38 Cr

Operating Cash Flowℹ

₹17.02 Cr

Financials at a glance

Restated Unspecified

Statement: Income StatementPeriod: Restated Multi-Year (FY)

Shareholding, Ownership & Dilution

6 disclosed holders

Pre-Offer Shareholding Distribution

Breakdown of major disclosed shareholders prior to the issue

100.00% Pre-Issue

100%Pre-Offer

Baiju Bhupendrabhai Desai

19.83%

Rushin Baijubhai Desai

19.00%

Patel Ghanshyam Arjanbhai

18.80%

Patel Shaileshbhai Arjanbhai

18.67%

Falguni Baijubhai Desai

9.83%

Others

13.87%

Ownership Impact of the IPO

What is newly issued, what changes hands, and what stays put

100.00% Post-Issue

100%POST-OFFER

Pre-IPO Retained

74.52%

Fresh-Issue Dilution

15.07%

OFS Changes Hands

10.41%

Total Company Offered in IPO25.48%

Calculated from share counts disclosed in the offer filing.

Disclosed Pre-Offer Shareholders Table

AI Summary

Filing-backed

Prospectus Research

Analyze business model, competitive strengths, use of issue proceeds, and disclosed risk factors with official page citations.

Issue intermediaries

Lead book managers

Oneview Corporate Advisors Private Limited, Valmiki Leela Capital Private Limited

Registrar to the issue

MUFG Intime India Private Limited

Listing venues

NSE,BSE

Listed Peer Valuation & Returns

Industry Avg P/E:56.25x

Swipe left / right to view all valuation metrics→

Company
Claroid Pharmaceuticals LimitedThis Issue	₹169.72 Cr	₹5.41	51.16%

Official Prospectus Filings

Claroid Pharmaceuticals Limited - DRHP Claroid Pharmaceuticals Limited - Draft Abridged Prospectus

Type: DRHP · Published: 2026-09-30

Claroid Pharmaceuticals Limited

Issue Timeline & Lifecycle

What Looks Strong

What to Watch

Profitability & Returns

Financial Health & Solvency

Disclosed Pre-Offer Shareholders Table

AI Summary

Prospectus Research

Issue intermediaries

Listed Peer Valuation & Returns

Official Prospectus Filings

Frequently Asked Questions